Committee paper for discussion on further information provided on Bonolive for the Committee’s consideration. The Committee is asked to consider whether it recommends authorisation of the product.
Committee Paper for Discussion on Oligonol on further information requested on two areas on which the applicant has responded. The Committee are asked to consider the response and whether they recommend the novel food for authorisation.
Committee paper for discussion on further information requested on DHA Rich Algal Oil by the Committee on whether it recommends authorisation of the extension of use of the product.
Committee paper for discussion on requested further information on a number of aspects of the dossier including the toxicology studies summarised in the dossier. This paper presents the Committee’s comments and conclusions on this study and the applicant’s response.
Committee paper for discussion on Vivinal® on whether their product Vivinal® GOS PT should be considered substantially equivalent with Vivinal® GOS already on the EU market.
Committee paper for discussion on a report entitled ‘New Techniques in Agricultural Biotechnology’ which was circulated to the Committee earlier this summer.
ACNFP Meeting Agenda 21st of September 2017